IAEA Resource Listings
2019
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
Dizdarevic, S. T., M.: McCready, V. R.: Mihailovic, J.: Vinjamuri, S.: Buscombe, J. R.: Lee, S. T.: Frangos, S.: Sathekge, M.: Siraj, Q.: Choudhury, P.: Bom, H.: Franceschi, M.: Ugrinska, A.: Paez, D.: Hussain, R.: Mailman, J.: Luster, M.: Virgolini, I. (2019). The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma. World J Nucl Med, 18(2), 123-126. doi:10.4103/wjnm.WJNM_117_18
2019
EANM Practice Guideline/SNMMI Procedure Standard for RAIU and Scintigraphy, V 3.0? (2019)
The purpose of this practice guideline/procedure standard is to assist imaging specialists and clinicians in recommending, performing, and interpreting the results of thyroid scintigraphy (including positron emission tomography) with various radiopharmaceuticals and radioiodine uptake test in patients with different thyroid diseases.